Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: prolactinoma (Click to remove) Prolactinomas NEJM 362:1219-1226, Klibanski,A., 2010 Prolactinoma NEJM 349:2035-2041, Schlechte,J.A., 2003 Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia NEJM 349:2023-2033, Colao,A.,et al, 2003 SUNCT Syndrome in Two Patient with Prolactinomas and Bromocriptine-Induced Attacks Neurol 58:1698-1699, Massiou,H.,et al, 2002 Management of Pituitary Tumors Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998 Diagnosis and Management of Hormone-Secreting Pituitary Adenomas NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991 Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502 Ann Int Med 112:668-673, Vance,M.L.,et al, 1990 Hyperprolactinaemia, Common and Treatable BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988 Giant Invasive Prolactinomas Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987 Prolactinomas Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985 Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas NEJM 313:656-659, Liuzzi,A.,et al, 1985 Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma Neurol 35:1193-1195, Kok,J.G.,et al, 1985 Showing articles 0 to 12 of 12